Here are the biggest movers of the day: Stock gainers: Coherus BioSciences stock
CHRS,
-3.65%
rose 17% as the Food and Drug Administration approved its treatment for nasopharyngeal cancer when combined with chemotherapy that it makes with Shanghai Junshi Biosciences.
Article Attribution | Read More at Article Source